3-Aryl-3-aryloxypropylamines

3-Aryl-3-aryloxyalkylamines of the general formula (I) (I) and their pharmaceutically acceptable acid addition salts, wherein R1, R2, R4 and R5 are hydrogen or lower alkyl, R3 is hydrogen, lower alkyl or benzyl, Ar is phenyl optionally substituted by one or more halogen, trifluoromethyl, lower alkyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHEPHERD, ROBIN G
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SHEPHERD
ROBIN G
description 3-Aryl-3-aryloxyalkylamines of the general formula (I) (I) and their pharmaceutically acceptable acid addition salts, wherein R1, R2, R4 and R5 are hydrogen or lower alkyl, R3 is hydrogen, lower alkyl or benzyl, Ar is phenyl optionally substituted by one or more halogen, trifluoromethyl, lower alkyl, lower alkoxy, nitro or amino groups, and Ar1 is methylsulphinyl, methylsulphonyl- or cyano-substituted phenyl, 2- or 4-pyridyl, 2-pyrazinyl, 2-quinolinyl, 2-thienyl or 2-thiazolyl exhibit activity on the central nervous system, e.g. as antidepressants.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US4330546A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US4330546A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US4330546A3</originalsourceid><addsrcrecordid>eNrjZJAx1nUsqszRNdZNBFL5FZUFRfkFlTmJuZl5qcU8DKxpiTnFqbxQmptB3s01xNlDN7UgPz61uCAxOTUvtSQ-NNjE2NjA1MTM0ZiwCgATKCMf</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3-Aryl-3-aryloxypropylamines</title><source>esp@cenet</source><creator>SHEPHERD; ROBIN G</creator><creatorcontrib>SHEPHERD; ROBIN G</creatorcontrib><description>3-Aryl-3-aryloxyalkylamines of the general formula (I) (I) and their pharmaceutically acceptable acid addition salts, wherein R1, R2, R4 and R5 are hydrogen or lower alkyl, R3 is hydrogen, lower alkyl or benzyl, Ar is phenyl optionally substituted by one or more halogen, trifluoromethyl, lower alkyl, lower alkoxy, nitro or amino groups, and Ar1 is methylsulphinyl, methylsulphonyl- or cyano-substituted phenyl, 2- or 4-pyridyl, 2-pyrazinyl, 2-quinolinyl, 2-thienyl or 2-thiazolyl exhibit activity on the central nervous system, e.g. as antidepressants.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>1982</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19820518&amp;DB=EPODOC&amp;CC=US&amp;NR=4330546A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19820518&amp;DB=EPODOC&amp;CC=US&amp;NR=4330546A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHEPHERD; ROBIN G</creatorcontrib><title>3-Aryl-3-aryloxypropylamines</title><description>3-Aryl-3-aryloxyalkylamines of the general formula (I) (I) and their pharmaceutically acceptable acid addition salts, wherein R1, R2, R4 and R5 are hydrogen or lower alkyl, R3 is hydrogen, lower alkyl or benzyl, Ar is phenyl optionally substituted by one or more halogen, trifluoromethyl, lower alkyl, lower alkoxy, nitro or amino groups, and Ar1 is methylsulphinyl, methylsulphonyl- or cyano-substituted phenyl, 2- or 4-pyridyl, 2-pyrazinyl, 2-quinolinyl, 2-thienyl or 2-thiazolyl exhibit activity on the central nervous system, e.g. as antidepressants.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1982</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAx1nUsqszRNdZNBFL5FZUFRfkFlTmJuZl5qcU8DKxpiTnFqbxQmptB3s01xNlDN7UgPz61uCAxOTUvtSQ-NNjE2NjA1MTM0ZiwCgATKCMf</recordid><startdate>19820518</startdate><enddate>19820518</enddate><creator>SHEPHERD; ROBIN G</creator><scope>EVB</scope></search><sort><creationdate>19820518</creationdate><title>3-Aryl-3-aryloxypropylamines</title><author>SHEPHERD; ROBIN G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US4330546A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1982</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>SHEPHERD; ROBIN G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHEPHERD; ROBIN G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3-Aryl-3-aryloxypropylamines</title><date>1982-05-18</date><risdate>1982</risdate><abstract>3-Aryl-3-aryloxyalkylamines of the general formula (I) (I) and their pharmaceutically acceptable acid addition salts, wherein R1, R2, R4 and R5 are hydrogen or lower alkyl, R3 is hydrogen, lower alkyl or benzyl, Ar is phenyl optionally substituted by one or more halogen, trifluoromethyl, lower alkyl, lower alkoxy, nitro or amino groups, and Ar1 is methylsulphinyl, methylsulphonyl- or cyano-substituted phenyl, 2- or 4-pyridyl, 2-pyrazinyl, 2-quinolinyl, 2-thienyl or 2-thiazolyl exhibit activity on the central nervous system, e.g. as antidepressants.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US4330546A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title 3-Aryl-3-aryloxypropylamines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T00%3A41%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHEPHERD;%20ROBIN%20G&rft.date=1982-05-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS4330546A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true